MIRAE ASSET
EMERGING BLUECHIP FUND - (MAEBF)
(Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks) Type of Scheme |
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks |
Investment Objective |
The investment objective of the scheme is to generate income and capital appreciation from a portfolio primarily investing in Indian equities and equity related securities of large cap and mid cap companies at the time of investment. From time to time, the fund manager may also seek participation in other Indian equity and equity related securities to achieve optimal Portfolio construction. The Scheme does not guarantee or assure any returns |
Fund Managers** |
Mr. Neelesh Surana, (since inception of the fund) and Mr. Ankit Jain (since January 31, 2019) |
Allotment Date |
09th July, 2010 |
Benchmark Index |
Nifty Large Midcap 250 (TRI) |
Minimum Investment Amount |
Fresh lumpsum subscription/switch-in to all the Plans & Options of Mirae Asset Emerging Bluechip Fund through any mode including Stock Exchange platform has been temporarily suspended with effect from October 25, 2016 |
Systematic Investment Plan (SIP) (Any Date SIP is available from 1st July, 2019) |
Fresh Registration through SIP shall be allowed for a maximum of up to ₹ 2,500/-(Rupees Two Thousand Five Hundred) through Monthly mode cumulatively aggregated across all available SIP Dates of each month (at Primary holder PAN level) before the applicable cut off time on any business day For Additional Details please refer notice-cum- addendum dated November 4, 2020 |
Load Structure |
Entry load: NA Exit load: I. For investors who have opted for SWP under the plan: a) 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil. b) Any redemption in excess of such limits in the first 365 days from the date of allotment shall be subject to the following exit load: (Redemption of units would be done on First In First Out Basis (FIFO): •If redeemed within 1 year (365 days) from the date of allotment: 1% •If redeemed after 1 year (365 days) from the date of allotment: NIL II. Other Redemptions: For Investors who have not opted for SWP under the plan (including Switch out, STP out): •If redeemed within 1 year (365 days) from the date of allotment: 1% •If redeemed after 1 year (365 days) from the date of allotment: NIL |
Plans Available |
Regular Plan and Direct Plan |
Options Available |
Growth Option and IDCW^ Option (Payout & Re-investment) |
Monthly Average AUM (₹ Cr.) as on Febraury 28, 2022 |
21,697.76 |
| Net AUM ( ₹ Cr.) | 21,083.72 |
Monthly Avg. Expense Ratio (Including Statutory Levies) as on Febraury 28, 2022 |
Regular Plan: 1.74% Direct Plan: 0.71% |
| **For experience of Fund Managers Click Here | |
| ^Pursuant to Notice cum addendum dated March 27, 2021 the nomenclature of dividend option has been changed w.e.f. April 01, 2021. | |
| NAV: | Direct | Regular |
| Growth | ₹ 100.840 | ₹ 92.542 |
| IDCW | ₹ 71.635 | ₹ 43.110 |
| Volatility | 22.13% |
| Beta: | 0.92 |
| R Squared | 0.98 |
| Sharpe Ratio#: | 0.91 |
| Information Ratio | 1.24 |
| Portfolio Turnover Ratio | 0.64 times |
@The Volatility, Beta, R Squared, Sharpe Ratio & Information Ratio are calculated on returns from last three years Monthly data points. # Risk free rate: FBIL OVERNIGHT MIBOR as on 28th February, 2022.^Basis last rolling 12 months. |
|
| Portfolio Holdings | % Allocation | |
| Banks | ||
| ICICI Bank Ltd | 6.30% | |
| HDFC Bank Ltd | 5.17% | |
| Axis Bank Ltd | 4.46% | |
| State Bank of India | 3.77% | |
| Kotak Mahindra Bank Ltd | 0.01% | |
| Software | ||
| Infosys Ltd | 5.16% | |
| MphasiS Limited | 2.30% | |
| Tata Consultancy Services Ltd | 1.91% | |
| HCL Technologies Limited | 1.62% | |
| Pharmaceuticals | ||
| Sun Pharmaceutical Industries Ltd | 2.33% | |
| Torrent Pharmaceuticals Ltd | 1.39% | |
| IPCA Laboratories Limited | 1.37% | |
| Ajanta Pharma Ltd | 1.26% | |
| Aurobindo Pharma Ltd | 1.05% | |
| Natco Pharma Limited | 0.98% | |
| Dr. Reddy's Laboratories Ltd | 0.33% | |
| Consumer Durables | ||
| Voltas Ltd | 1.93% | |
| Crompton Greaves Consumer Electricals Limited | 1.43% | |
| Bata India Limited | 1.38% | |
| Havells India Ltd | 1.05% | |
| Titan Company Ltd | 0.05% | |
| Finance | ||
| Shriram Transport Finance Company Limited | 1.14% | |
| Housing Development Finance Corporation Ltd | 1.10% | |
| Power Finance Corporation Ltd | 1.10% | |
| SBI Cards and Payment Services Limited | 0.94% | |
| Cholamandalam Investment and Finance Company Limited | 0.78% | |
| Insurance | ||
| Max Financial Services Ltd | 2.47% | |
| HDFC Life Insurance Company Ltd | 1.16% | |
| SBI Life Insurance Company Limited | 1.01% | |
| ICICI Lombard General Insurance Company Limited | 0.40% | |
| Auto | ||
| Tata Motors Limited | 1.58% | |
| Maruti Suzuki India Ltd | 1.47% | |
| Ashok Leyland Limited | 1.22% | |
| TVS Motor Company Ltd | 0.59% | |
| Consumer Non Durables | ||
| Emami Limited | 1.74% | |
| ITC Ltd | 1.35% | |
| Britannia Industries Ltd | 0.52% | |
| Kansai Nerolac Paints Limited | 0.49% | |
| Hindustan Unilever Ltd | 0.25% | |
| Dabur India Ltd | 0.00% | |
| Petroleum Products | ||
| Reliance Industries Ltd | 3.30% | |
| Bharat Petroleum Corporation Limited | 0.61% | |
| Hindustan Petroleum Corporation Ltd | 0.34% | |
| Chemicals | ||
| Vinati Organics Ltd | 1.64% | |
| Atul Limited | 1.35% | |
| Chemplast Sanmar Limited | 0.85% | |
| Cement & Cement Products | ||
| JK Cement Limited | 2.30% | |
| Nuvoco Vistas Corporation Limited | 1.07% | |
| Auto Ancillaries | ||
| Balkrishna Industries Ltd | 1.43% | |
| Sona BLW Precision Forgings Limited | 1.29% | |
| CEAT Limited | 0.61% | |
| Industrial Products | ||
| SKF India Limited | 2.23% | |
| Prince Pipes And Fittings Limited | 0.70% | |
| Gas | ||
| Gujarat State Petronet Limited | 2.41% | |
| Ferrous Metals | ||
| Tata Steel Ltd | 2.17% | |
| Capital Markets | ||
| Indian Energy Exchange Ltd | 1.01% | |
| UTI Asset Management Company Limited | 0.87% | |
| Construction Project | ||
| Larsen & Toubro Ltd | 1.86% | |
| Telecom - Services | ||
| Bharti Airtel Ltd | 1.74% | |
| Healthcare Services | ||
| Krishna Institute Of Medical Sciences Limited | 0.97% | |
| Fortis Healthcare Limited | 0.59% | |
| Textile Products | ||
| Page Industries Ltd | 1.45% | |
| Power | ||
| NTPC Ltd | 1.19% | |
| Pesticides | ||
| Bayer Cropscience Limited | 0.85% | |
| Transportation | ||
| Gateway Rail Freight Limited | 0.84% | |
| Aerospace & Defense | ||
| Bharat Electronics Ltd | 0.77% | |
| Financial Technology (FINTECH) | ||
| One 97 Communications Limited | 0.37% | |
| Non - Ferrous Metals | ||
| National Aluminium Company Limited | 0.22% | |
| Retailing | ||
| Zomato Limited | 0.04% | |
| Equity Holding Total | 99.64% | |
| Cash & Other Receivables | 0.36% | |
| Total | 100.00% | |
| New Position Bought |
| Stock |
| Finance |
| Cholamandalam Investment and Finance Company Ltd |
| Positions Increased |
| Stock |
| Consumer Non Durables |
| ITC Limited |
| Kansai Nerolac Paints Limited |
| Britannia Industries Limited |
| Pharmaceuticals |
| Aurobindo Pharma Limited |
| Non - Ferrous Metals |
| National Aluminium Company Limited |
| Petroleum Products |
| Hindustan Petroleum Corporation Limited |
| Reliance Industries Limited |
| Bharat Petroleum Corporation Limited |
| Capital Markets |
| Indian Energy Exchange Limited |
| UTI Asset Management Company Limited |
| Insurance |
| HDFC Life Insurance Company Limited |
| Industrial Products |
| Prince Pipes And Fittings Limited |
| Consumer Durables |
| Crompton Greaves Consumer Electricals Limited |
| Bata India Limited |
| Pesticides |
| Bayer Cropscience Limited |
| Auto Ancillaries |
| Balkrishna Industries Limited |
| Aerospace & Defense |
| Bharat Electronics Limited |
| Healthcare Services |
| Krishna Institute Of Medical Sciences Limited |
| Positions Decreased |
| Stock |
| Auto |
| Ashok Leyland Limited |
| Maruti Suzuki India Limited |
| Banks |
| Axis Bank Limited |
| HDFC Bank Limited |
| Software |
| Tata Consultancy Services Limited |
| Chemicals |
| Atul Limited |
| Consumer Durables |
| Voltas Limited |
| Titan Company Limited |
| Pharmaceuticals |
| Natco Pharma Limited |
| Ajanta Pharma Limited |
| Record Date | IDCW (₹) | Face Value (₹) | Cum Nav (₹) |
06-Dec-18 |
2.21 per Unit |
10 |
28.972 |
16-Jan-20 |
2.21 per Unit |
10 |
32.767 |
15-Mar-21 |
3.25 per Unit |
10 |
40.346 |
Past Performance may or may not be sustained in future. Pursuant to payment of IDCW the NAV of the IDCW option of the scheme will fall to the extent of payout and statutory levy (if any). IDCW history is for MAEBF- Regular Plan - IDCW Option
| Returns (in%) | ||||
| 1 Yr | 3 Yrs | 5 Yrs | SI | |
| MAEBF | 19.40% |
23.49% |
17.88% |
21.05% |
| Scheme Benchmark* | 19.50% |
19.72% |
15.14% |
13.13% |
| Additional Benchmark** | 15.65% |
17.49% |
15.73% |
11.86% |
| NAV as on 28th February, 2022 | 92.542 | |||
| Index Value (28th February, 2022) | Index Value of Scheme benchmark is 11,610.45 and S&P BSE Sensex (TRI) is 84,075.57 | |||
| Allotment Date | 9th July, 2010 | |||
| Scheme Benchmark | *Nifty Large Midcap 250 (TRI) | |||
| Additional Benchmark | **S&P BSE Sensex (TRI) | |||
Fund managers : Mr. Neelesh Surana managing the scheme since 9th July, 2010 & Mr. Ankit Jain since 31st ,January 2019)
Note: Returns below or for 1 year are absolute returns, returns above 1 year are CAGR- Compounded Annualized Growth returns.
| Period | Total Amount Invested | Mkt Value as on 28-February-2022 |
SIP |
1,390,000 |
5,557,144 |
10 Yrs |
1,200,000 |
3,932,505 |
7 Yrs |
840,000 |
1,679,572 |
5 Yrs |
600,000 |
990,669 |
3 Yrs |
360,000 |
527,692 |
1 Yr |
120,000 |
123,304 |
Returns (%) |
Period |
|||||
SI |
10yrs |
7yrs |
5yrs |
3yrs |
1yr |
|
Fund Return& (%) |
22.22 |
22.47 |
19.47 |
20.19 |
26.55 |
5.19 |
Benchmark Return& (%) |
15.73 |
16.44 |
16.17 |
17.56 |
25.05 |
6.31 |
Add. Benchmark Return& (%) |
13.73 |
14.39 |
15.25 |
16.53 |
20.22 |
7.06 |
& The SIP returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month.
This product is suitable for investors who are seeking*
• Long term capital appreciation
• Large & Midcap fund investing atleast 35% in largecap stock & atleast 35% in midcap stocks
*Investors should consult their financial advisers if they are not clear about the suitability of the product.
Past Performance may or may not be sustained in future.
Note : For computation of since inception returns (%) the allotment NAV has been taken as ₹ 10.00. The performance of other funds managed by the same fund managers are given in the respective page of the schemes 
Different Plans under the scheme has different expense structure. The reference and details provided here in are of Regular Plan - Growth Option